The research study is being conducted to test an experimental vaccine to potentially prevent
cancer for people with BRCA1 or BRCA2 mutations. This study will test if the vaccine is safe
(without significant side effects) and test a new way of administering vaccines. It will also
test whether the vaccine activates your immune system.
Phase:
Phase 1
Details
Lead Sponsor:
Abramson Cancer Center of the University of Pennsylvania University of Pennsylvania